UBS Group Lowers UnitedHealth Group (NYSE:UNH) Price Target to $410.00

UnitedHealth Group (NYSE:UNH) had its target price cut by investment analysts at UBS Group from $430.00 to $410.00 in a note issued to investors on Wednesday,Benzinga reports. The firm currently has a “buy” rating on the healthcare conglomerate’s stock. UBS Group’s target price indicates a potential upside of 40.75% from the company’s current price.

UNH has been the topic of several other research reports. Mizuho lifted their price target on shares of UnitedHealth Group from $300.00 to $430.00 and gave the stock an “outperform” rating in a research note on Thursday, October 9th. Evercore ISI raised shares of UnitedHealth Group to a “strong-buy” rating in a report on Tuesday, January 6th. Morgan Stanley cut their target price on shares of UnitedHealth Group from $411.00 to $409.00 and set an “overweight” rating for the company in a research note on Friday, January 23rd. Zacks Research raised shares of UnitedHealth Group from a “strong sell” rating to a “hold” rating in a research note on Monday, October 6th. Finally, Deutsche Bank Aktiengesellschaft cut UnitedHealth Group from a “buy” rating to a “hold” rating and set a $333.00 target price for the company. in a report on Wednesday, October 29th. One investment analyst has rated the stock with a Strong Buy rating, seventeen have given a Buy rating, nine have issued a Hold rating and two have assigned a Sell rating to the stock. According to MarketBeat.com, UnitedHealth Group currently has a consensus rating of “Moderate Buy” and an average price target of $385.71.

UnitedHealth Group Stock Up 3.0%

UnitedHealth Group stock traded up $8.60 during trading on Wednesday, reaching $291.30. The stock had a trading volume of 10,193,796 shares, compared to its average volume of 10,691,284. The business has a 50 day moving average price of $332.08 and a 200 day moving average price of $323.81. The stock has a market cap of $263.87 billion, a PE ratio of 15.20, a P/E/G ratio of 2.12 and a beta of 0.42. UnitedHealth Group has a 52-week low of $234.60 and a 52-week high of $606.36. The company has a quick ratio of 0.82, a current ratio of 0.82 and a debt-to-equity ratio of 0.71.

UnitedHealth Group (NYSE:UNH) last announced its earnings results on Tuesday, January 27th. The healthcare conglomerate reported $2.11 EPS for the quarter, beating analysts’ consensus estimates of $2.09 by $0.02. The business had revenue of $113.22 billion during the quarter, compared to analysts’ expectations of $113.38 billion. UnitedHealth Group had a net margin of 4.04% and a return on equity of 19.23%. The business’s revenue was up 12.3% compared to the same quarter last year. During the same period in the prior year, the company earned $6.81 earnings per share. UnitedHealth Group has set its FY 2026 guidance at 17.750- EPS. On average, analysts predict that UnitedHealth Group will post 29.54 EPS for the current year.

Institutional Investors Weigh In On UnitedHealth Group

Several institutional investors and hedge funds have recently modified their holdings of the stock. LFA Lugano Financial Advisors SA purchased a new position in UnitedHealth Group during the second quarter valued at $25,000. Beacon Financial Strategies CORP purchased a new position in shares of UnitedHealth Group during the 4th quarter valued at $26,000. Foster Dykema Cabot & Partners LLC lifted its holdings in shares of UnitedHealth Group by 69.4% in the third quarter. Foster Dykema Cabot & Partners LLC now owns 83 shares of the healthcare conglomerate’s stock worth $29,000 after buying an additional 34 shares in the last quarter. 1248 Management LLC purchased a new stake in shares of UnitedHealth Group during the 3rd quarter worth approximately $29,000. Finally, Holos Integrated Wealth LLC purchased a new position in UnitedHealth Group in the fourth quarter worth about $29,000. 87.86% of the stock is owned by hedge funds and other institutional investors.

UnitedHealth Group News Summary

Here are the key news stories impacting UnitedHealth Group this week:

• Positive Sentiment: Modest EPS beat and business strengths — UNH reported Q4 EPS of $2.11, slightly above expectations, with Optum Rx and segments showing pockets of operational strength that helped earnings outpace the headline revenue miss. UnitedHealth posts modest earnings beat, soft revenue guidance as insurer plots turnaround
• Positive Sentiment: Profit outlook roughly in line with expectations — management forecast 2026 adjusted profit slightly above analyst estimates, suggesting cost-control measures are starting to take hold. UnitedHealth forecasts 2026 profit slightly above estimates
• Positive Sentiment: Capital returns remain a tailwind — investors note that dividends and buybacks are expected to continue, supporting shareholder value even after the pullback. Trump Triggers Buying Opportunity in UnitedHealth Group
• Neutral Sentiment: Earnings-call detail and guidance specifics available — the full Q4 earnings call transcript and company release outline the drivers behind results and the assumptions behind 2026 guidance. Useful for modeling revenue and margin scenarios. UnitedHealth Group (UNH) Q4 2025 earnings call transcript
• Neutral Sentiment: Company issued 2026 guidance — UNH set FY2026 EPS guidance (~17.75) and revenue guidance near $439B, which frames analysts’ models and is central to the market reaction. UnitedHealth Group Reports 2025 Results and Issues 2026 Outlook
• Negative Sentiment: Revenue guidance implies the first annual revenue decline in decades — management signaled roughly a 2% revenue drop in 2026 as part of a “right-sizing” and turnaround, which hurt growth expectations. UnitedHealth forecasts first revenue drop in nearly four decades; shares plunge
• Negative Sentiment: Medicare-rate proposal was the catalyst — a Trump administration proposal to keep Medicare Advantage payments roughly flat (well below expectations) sharply reduced forward reimbursement assumptions for insurers, triggering broad selling in the sector. Here’s Why Health Insurance Stocks Are Sinking Tuesday
• Negative Sentiment: Restructuring hit and one‑time charges — UNH took a ~$1.6B restructuring charge in Q4 tied to turnaround actions, which pressured near-term earnings and raised execution risk. UnitedHealth Takes $1.6 Billion Hit To Earnings Amid Restructuring
• Negative Sentiment: Market impact and reputational scrutiny — the stock plunged sharply (dragging the Dow), drew analyst downgrades, and faces scrutiny after reports of lawmakers selling UNH ahead of the rout, adding reputational and political risk. These 3 U.S. politicians suspiciously dumped UnitedHealth stock weeks before crash

About UnitedHealth Group

UnitedHealth Group Inc is a diversified health care company headquartered in Minnetonka, Minnesota, that operates two primary business platforms: UnitedHealthcare and Optum. Founded in 1977, the company provides a broad range of health benefits and health care services to individuals, employers, governmental entities and other organizations. Its operations span commercial employer-sponsored plans, individual and Medicare and Medicaid programs, and services for customers and health systems in the United States and selected international markets.

UnitedHealthcare is the company’s benefits business, administering health plans and networks, managing provider relationships, and offering coverage products for employers, individuals, and government-sponsored programs.